21 Patents
- 0 cites
- 0 cites
- 0 cites
- US125437112026Non-human Animals Expressing Ph-sensitive Immunoglobulin Sequences
Regeneron Pharmaceuticals, Inc
0 cites - 0 cites
- US124332642025Non-human Animals Having an Engineered Immunoglobulin Lambda Light Chain Locus
Regeneron Pharmaceuticals, Inc.
0 cites - US124332652025Non-human Animals Having a Humanized a Proliferation-inducing Ligand Gene
Regeneron Pharmaceuticals, Inc.
0 cites - US124090682025Patient Interface Devices and Methods and Systems for Combined Sonic and Laser Applications
Lensar, Inc.
0 cites - US123898882025Mice Expressing a Limited Immunoglobulin Light Chain Repertoire
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US123714752025Nucleic Acids Encoding Anchor Modified Antibodies and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US122953542025Non-human Animals Expressing Exogenous Terminal Deoxynucleotidyltransferase
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US116660402023Humanized Non-human Animals with Restricted Immunoglobulin Heavy Chain Loci
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US115769842023Genetically Modified Mouse with Humanized Immunoglobulin Heavy Chain Constant Region Genes and Method of Using
Regeneron Pharmaceuticals, Inc.
0 cites - US115590502023Humanized Non-human Animals with Restricted Immunoglobulin Heavy Chain Loci
Regeneron Pharmaceuticals, Inc.
0 cites